To our knowledge, this is the first and largest WGS study of BRCA1/2 modifiers to date, and we report PPARGC1A as a novel putative genetic modifier of ovarian and breast cancer risk for BRCA1/2 carriers. This evidence concerns the gene PPARGC1A and breast cancer.